Physical Medicine & Rehabilitation, Pain Medicine · San Antonio, TX
NPI
1548273501
Since 2006
Specialty
Physical Medicine & Rehabilitation, Pain Medicine
Code 2081P2900X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
21 Spurs Lane, Suite 240
San Antonio, TX, 78240
Phone (210) 690-0777
Groups this clinician bills Medicare through
Medicare paid, 2024
$870K
19,734 services
Medicare patients, 2024
964
Average age 75
Drug cost, 2024
$487K
2,950 prescriptions
Company payments, 2025
$7,608
From 24 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ellen W Lin was code J1010 (injection, methylprednisolone acetate, 1 mg), 11,857 times for 133 patients. In total Ellen W Lin billed 19,734 services in 71 codes, and Medicare paid $870K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-05-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 11,857 | 133 | $0.10 | $1,194 |
| J2250 Injection, midazolam hydrochloride, per 1 mg | Office | 1,412 | 342 | $0.11 | $153 |
| Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | Office | 1,130 | 258 | $0.28 | $321 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 847 | 461 | $0.09 | $79.57 |
| 99152 Anesthesia | Office | 383 | 315 | $40.34 | $15K |
| 99214 Office E&M - Established | Office | 356 | 282 | $91.06 | $32K |
| 64636 Destruction by Neurolytic Agent - Back | Office | 287 | 219 | $286.24 | $82K |
| 64635 Destruction by Neurolytic Agent - Back | Office | 274 | 224 | $510.47 | $140K |
| 99213 Office E&M - Established | Office | 269 | 216 | $67.58 | $18K |
| 64493 Nerve Block Injection - Back | Office | 237 | 151 | $199.67 | $47K |
| 64494 Nerve Block Injection - Back | Office | 231 | 149 | $110.14 | $25K |
| 64483 Nerve Block Injection - Back | Office | 184 | 157 | $221.71 | $41K |
| 99204 Office E&M - New | Office | 177 | 177 | $129.95 | $23K |
| J0690 Injection, cefazolin sodium, 500 mg | Office | 176 | 53 | $0.63 | $110 |
| 64490 Nerve Block Injection - Back | Office | 168 | 101 | $220.76 | $37K |
By year: 2022 $814K for 9,469 services; 2023 $969K for 8,789 services; 2024 $870K for 19,734 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80305 Drug Tests | 37 | 37 | $12.35 | $457 |
Medicare prescription drug claims, 2024
In 2024, the drug Ellen W Lin prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 975 prescriptions and refills. In total Ellen W Lin wrote 2,950 Medicare prescriptions that cost $487K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 975 | 978 | 181 | $25K |
| Baclofen Generic | 197 | 243 | 92 | $2,243 |
| Tramadol Hcl Generic | 182 | 182 | 76 | $1,177 |
| Gabapentin Generic | 152 | 199 | 55 | $1,721 |
| Acetaminophen-Codeine Acetaminophen With Codeine | 127 | 129 | 68 | $3,332 |
| Pregabalin Generic | 111 | 137 | 29 | $1,881 |
| Nucynta Tapentadol Hcl | 99 | 99 | 16 | $175K |
| Tizanidine Hcl Generic | 85 | 121 | 30 | $1,116 |
| Belbuca Buprenorphine Hcl | 73 | 73 | 23 | $54K |
| Meloxicam Generic | 72 | 88 | 24 | $176 |
| Methocarbamol Generic | 67 | 93 | 22 | $1,378 |
| Nucynta Er Tapentadol Hcl | 52 | 52 | Under 11 | $104K |
| Cyclobenzaprine Hcl Generic | 44 | 72 | 17 | $655 |
| Doxepin Hcl Generic | 42 | 58 | 15 | $465 |
| Methylprednisolone Generic | 38 | 38 | 35 | $211 |
Brand drugs: 320 claims; generic drugs: 2,630 claims; opioid claims: 1,639.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ellen W Lin $7,608 ($7,608 in general payments such as food, travel and fees) from 24 companies. The largest payer was Globus Medical, Inc. with $6,136.
| Company | Payments | Amount |
|---|---|---|
| Globus Medical, Inc. GMED | 120 | $6,136 |
| MML US, Inc. | 2 | $259 |
| Pfizer Inc. PFE | 15 | $182 |
| Collegium Pharmaceutical, Inc. COLL | 15 | $143 |
| HydroCision, Inc. | 1 | $120 |
| SPR Therapeutics, Inc | 1 | $103 |
| Lundbeck LLC | 4 | $95.96 |
| AngioDynamics, Inc. ANGO | 1 | $93.46 |
| Teva Pharmaceuticals USA, Inc. TEVA | 3 | $81.16 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 2 | $56.47 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.